Bio-Rad Laboratories, Inc. (BIO.B)

Bio-Rad Laboratories Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-675.9	-1,844	-637.3	-3,628	4,254	3,814
Depreciation & Amortization	162.1	151.6	145.9	137.3	137.6	175.7
Loss (Gain) From Sale of Assets	-	-	-2.5	-1.4	-	-11.7
Asset Writedown & Restructuring Costs	-	29.5	-	-	-	-
Loss (Gain) From Sale of Investments	1,112	2,657	1,252	5,206	-4,925	-4,491
Stock-Based Compensation	58.5	62.3	61.3	60.9	51.2	41.6
Other Operating Activities	31.5	20	-12	22.1	8.74	-32.53
Change in Accounts Receivable	6.3	16.2	11.4	-87.4	-20.4	-15
Change in Inventory	41.8	8.5	-46.3	-158.8	46.1	-52.1
Change in Accounts Payable	-15.3	-40.9	-51.8	-94.2	69.9	124.7
Change in Income Taxes	-9.8	24.1	-21.3	-1.2	-28.8	39
Change in Other Net Operating Assets	17.3	-1.9	-2.2	-26.8	-8.6	10.9
Operating Cash Flow	491.5	455.2	374.9	194.4	669.5	585
Operating Cash Flow Growth	19.30%	21.42%	92.85%	-70.96%	14.44%	27.76%
Capital Expenditures	-154.7	-165.6	-156.7	-112.8	-133.75	-108.56
Sale of Property, Plant & Equipment	0.1	0.1	0.2	0.2	0.05	0.07
Cash Acquisitions	-218.5	-	-	-100.7	-125.52	-96.66
Divestitures	-	-	2.5	1.4	-	12.24
Sale (Purchase) of Intangibles	-	-23.4	-	-1.5	-	3.41
Investment in Securities	187.1	28.7	174.2	-994.2	-84.73	119.6
Investing Cash Flow	-186	-160.2	20.2	-1,208	-797.38	-69.89
Long-Term Debt Issued	-	-	-	1,186	-	-
Long-Term Debt Repaid	-	-0.4	-0.5	-0.5	-3.02	-426.94
Net Debt Issued (Repaid)	-0.3	-0.4	-0.5	1,186	-3.02	-426.94
Issuance of Common Stock	15.8	19.2	18.5	17.6	20.63	20.2
Repurchase of Common Stock	-298.2	-207	-443.6	-229.7	-72.48	-112.93
Other Financing Activities	-30	-30.6	-	-	-0.56	-3.37
Financing Cash Flow	-312.7	-218.8	-425.6	973.6	-55.43	-523.04
Foreign Exchange Rate Adjustments	-6.8	9.2	0.4	3	-12.64	12.43
Miscellaneous Cash Flow Adjustments	-	-	-	-	-0.04	-0.03
Net Cash Flow	-14	85.4	-30.1	-36.6	-195.98	4.46
Free Cash Flow	336.8	289.6	218.2	81.6	535.75	476.44
Free Cash Flow Growth	36.34%	32.72%	167.40%	-84.77%	12.45%	32.58%
Free Cash Flow Margin	13.17%	11.28%	8.17%	2.91%	18.33%	18.72%
Free Cash Flow Per Share	12.24	10.26	7.47	2.74	17.74	15.80
Cash Income Tax Paid	78	99.4	129.6	158.3	134.68	65.24
Levered Free Cash Flow	235.02	180.86	106.85	2.86	485.98	427.88
Unlevered Free Cash Flow	265.7	211.43	137.72	26.68	486.95	441.54
Change in Working Capital	-197.7	-620.8	-432.8	-1,610	1,143	1,089

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q